A

AFC-HD AMS Life Science Co Ltd
TSE:2927

Watchlist Manager
AFC-HD AMS Life Science Co Ltd
TSE:2927
Watchlist
Price: 877 JPY 1.04% Market Closed
Market Cap: ¥12.8B

AFC-HD AMS Life Science Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

AFC-HD AMS Life Science Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
A
AFC-HD AMS Life Science Co Ltd
TSE:2927
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shiseido Co Ltd
TSE:4911
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Rohto Pharmaceutical Co Ltd
TSE:4527
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kao Corp
TSE:4452
Research & Development
-¥61.1B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
F
Fancl Corp
TSE:4921
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Research & Development
-¥9.1B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

AFC-HD AMS Life Science Co Ltd
Glance View

Market Cap
12.8B JPY
Industry
Consumer products

AFC-HD AMS Life Science Co., Ltd. engages in the manufacture of health food and cosmetics. The company is headquartered in Shizuoka-Shi, Shizuoka-Ken and currently employs 793 full-time employees. The company went IPO on 2005-03-03. The firm is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The firm operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The firm is also engaged in the management of restaurants through subsidiary.

Intrinsic Value
1 279.04 JPY
Undervaluation 31%
Intrinsic Value
Price ¥877
A

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett